A new protocol after heart attacks could slash risk of repeat events

NCT ID NCT07773272

First seen Aug 19, 2026 ยท Last updated Aug 19, 2026

Summary

This trial tests whether starting a comprehensive, guideline-based treatment plan immediately after a heart attack can reduce the chance of another heart attack, stroke, or death. The plan targets key risk factors like high cholesterol, high blood pressure, and diabetes using a combination of medications. About 1,200 adults who had a heart attack and underwent a stent procedure will be enrolled. Half will receive this rapid protocol, while the other half gets standard care, and outcomes are compared over two years.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
Rapid ESC-guideline-based secondary prevention protocol including lipid-lowering, antihypertensive, SGLT-2 inhibitors, and GLP-1 agonists
What this could lead to
If effective, this approach could become a standard protocol to prevent recurrent heart attacks and strokes, improving survival and quality of life.
What could go wrong
The trial is testing a protocol, not a single drug, so results may vary. It's uncertain whether the rapid approach will outperform standard care in reducing events.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE CORONARY SYNDROME (ACS) UNDERGOING PERCUTANEOUS CORONARY INTERVENTION (PCI) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Cardiology

    RECRUITING

    Heerlen, Limburg, 6419 PC, Netherlands

More trials for these conditions

Other studies related to the condition(s) this trial covers.